The Cancer Genome Atlas database and Gene Expression Profile Interaction Analysis 2 results showed that SUCLG2 expression levels were significantly higher in GBM samples than in normal tissues (Figs. 1C, S1A). This evidence concerns the gene SUCLG2 and cancer.